Rofecoxib

This classification denotes a cyclooxygenase inhibitor with the molecular formula C17H14O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0QTW8Z7MCR, chemically known as 2(5h)-furanone, 4-(4-(methylsulfonyl)phenyl)-3-phenyl- but generally known as rofecoxib, which bears US NIH Compound Identifier 5090. European Medicines Agency schedules Rofecoxib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04261MIG. The term ROFECOXIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules rofecoxib in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, ROFECOXIB remains the US FDA Preferred Term for this commodity. Rofecoxib bears US NLM identifiers UMLS ID C0762662 and NCI Concept Code C1832. SMILES: S(=O)(=O)(C1CCC(C2=C(C3CCCCC3)C(=O)OC2)CC1)C.